The latest evaluation from international health institutions shows remarkable gains, reflecting years of strategic planning and system-wide reform.

The Kingdom secured a score of 83 points in the most recent UHC update, marking an impressive rise of nine points in just two years.

This places the country among those with high-level health service coverage, a position earned through continuous investment in quality, accessibility and system readiness.

Saudi Arabia’s health advancement aligns closely with the goals of Vision 2030, particularly the Health Sector Transformation Program that aims to build a preventive, patient-centered and digitally enabled healthcare ecosystem.

Over the past two decades, steady improvements in coverage and service reliability have strengthened public health outcomes across the Kingdom.

The UHC Service Coverage Index, recognized globally as part of the Sustainable Development Goals, measures essential healthcare access across preventive services, disease treatment and system capacity.

Saudi Arabia’s strong performance signals not only improved service delivery but also a deeper focus on long-term national welfare and social development.

These improvements are closely associated with enhanced quality of life, reduced disease burden and greater resilience in the health sector.

With expanded primary care networks, early detection programs and digital health innovations, the system now supports citizens and residents more effectively than ever before.

A powerful driver of progress has been the Kingdom’s renewed emphasis on preventive care, encouraging early screenings and empowering primary healthcare centers.

These measures help detect chronic conditions earlier, reduce complications and improve long-term health outcomes across the population.

Rapid digitalization has also accelerated reform, with platforms such as Sehhaty and the Seha Virtual Hospital expanding access to care regardless of location.

These tools have streamlined appointments, consultations and medical records, improving efficiency and enhancing patient experience nationwide.

The health transformation has produced measurable achievements, particularly in life expectancy, which increased from 74 years in 2016 to 79.7 years in 2025.

This puts Saudi Arabia within reach of its Vision 2030 target of 80 years, demonstrating the effectiveness of integrated preventive and treatment strategies.

Health Minister Fahad Abdulrahman AlJalajel emphasized that the progress reflects strong leadership support and a unified national effort.

He noted that prioritizing prevention, strengthening primary care and advancing digital health solutions has created real improvements in both service quality and population well-being.

He highlighted that raising life expectancy to 79.7 years showcases the success of coordinated health initiatives built around people’s needs.

This achievement is a testament to the Kingdom’s commitment to building a healthier, more resilient society.

Saudi Arabia’s improvement in the UHC index also enhances its position among G20 countries, showcasing its dedication to high-standard healthcare and sustainable development.

By focusing on efficiency, readiness and innovation, the Kingdom continues to place individuals at the center of its national progress.

The latest advancements affirm that Saudi Arabia is on a strong path toward a modernized, people-focused health system capable of meeting future challenges.

With continued investment and visionary leadership, the Kingdom remains committed to shaping one of the most advanced healthcare landscapes in the region.

The visit included several strategic meetings with senior German officials aimed at expanding cooperation in public health, regulatory systems, research innovation and healthcare infrastructure.

AlJalajel held discussions with German Health Minister Nina Warken to explore joint initiatives in public health, medical research, disease prevention and long-term innovation strategies.

Both officials highlighted the importance of scientific collaboration and recognized the growing need for shared solutions that strengthen global health resilience.

The meeting underscored opportunities for increased research links between Saudi and German universities, medical centers and biomedical laboratories working on advanced technologies.

The minister also met with Germany’s Federal Joint Committee, where he examined governance models that support quality control, health regulation and service efficiency.

Talks included reviews of clinical standards, monitoring systems and frameworks that guide patient safety, treatment evaluation and health-sector performance.

AlJalajel further engaged with the Federal Institute for Risk Assessment to learn about Germany’s scientific methods for risk analysis, product safety and public health protection.

These discussions provided insight into regulatory processes that help maintain high-quality systems, improve transparency and support evidence-based decision-making.

A key part of the visit included a tour of Bayer’s global headquarters, where the minister met leaders from the pharmaceutical and biotechnology sectors to explore new collaboration opportunities.

The meeting focused on pharmaceutical innovation, digital health platforms and the potential development of advanced research partnerships tailored to future healthcare needs.

The discussions also covered technology transfer programs and the possibility of expanding cooperation to support Saudi Arabia’s growing pharmaceutical manufacturing capabilities.

AlJalajel participated in a roundtable hosted by the German Chamber of Commerce and Industry, bringing together leaders from health companies, scientific institutions and innovation-focused organizations.

During the session, participants explored investment opportunities in Saudi Arabia’s evolving health sector including digital platforms, medical devices, biotechnology initiatives and research-intensive projects.

The minister emphasized the significant progress underway within Saudi Arabia’s healthcare transformation,including reforms designed to enhance service quality, improve infrastructure and strengthen private-sector participation.

A major development during the roundtable was the signing of agreements between the Saudi National Unified Procurement Company and several German firms to enhance supply-chain capacity.

These agreements aim to localize medical technologies in the Kingdom and ensure long-term availability of specialized products, tools and materials essential for health-sector growth.

AlJalajel also met with Saudi students studying in Germany where he praised their dedication and contributions to the Kingdom’s expanding healthcare and scientific fields.

He highlighted the government’s commitment to empowering young talent by providing education pathways, training programs and opportunities that support Saudi Arabia’s national development goals.

The visit reaffirmed the strength of Saudi–German cooperation at a time when both countries are looking to advance technology-driven healthcare solutions and research innovation.

Discussions throughout the trip emphasized the value of global partnerships as Saudi Arabia works to modernize its health sector, expand its research ecosystem and build sustainable medical capabilities.

The outcomes of the visit reflect ongoing efforts to establish integrated health ecosystems, strengthen international collaboration and position the Kingdom as a regional leader in medical innovation.

AlJalajel’s visit marked another step in Saudi Arabia’s broader strategy to accelerate health-sector development, enhance global ties and invest in a knowledge-driven future.